EPS Revisions Current Qtr Sep-05 Next Qtr Dec-05 Current Year Dec-05 Next Year Dec-06 Up Last 7 Days 9 7 11 7 Up Last 30 Days 8 8 11 7 Down Last 30 Days 2 5 2 10 Down Last 90 Days 1 4 2 9
Unfortunately, it did not copy well
In the last 7 days, 9 analysts increased eps for the Sep qtr, 7 increased estimates for the Dec qtr, 11 for F/Y 2005 and 7 increased estimates for 2006. It appears that their take on 7/19's CC was good. A reasonable resolution to the Medinol litigation will push the stock back to $30 (I hope). JNJ litigation will not be resolved for at least 18 months. I believe that we need to see something coming out of the pipeline/past acquisition to give us an upward catalyst. Unforetunately, I don't see that happening
A web site that shows different analysts upgrades/downgrades and price targets is at newrating.com...not sure if you use that site or not. If you go and read all but one have a buy rating on the stock but the price target varies from 27-55/share. Golly, I wonder which one is right.
Thanks for the info on newrating.com. It is nice to get a reply about the company instead of opinions about one's character. I read this site a lot, but don't post very often. There are a few authors that post good info. I am desperately trying to find out what is going on with the the Medinol litigation